期刊文献+

G-CSF对供者淋巴细胞分泌IL-2功能的影响及临床意义 被引量:2

Impact on IL-2 Expression of Lymphocytes in Donors after G-CSF Administration and Its Clinical Significance
下载PDF
导出
摘要 为了研究异基因骨髓移植供者使用粒细胞集落刺激因子 (granulocytecolony stimulatingfactor,G CSF)对骨髓及外周血淋巴细胞分泌白细胞介素 2 (IL 2 )的影响 ,进一步探讨G CSF可能通过改变细胞因子分泌平衡而减轻急性移植物抗宿主病 (aGVHD)的发生 ,以 7例健康供者为对象 ,在其应用G CSF前后通过胞内细胞因子染色技术及流式细胞术 ,检测淋巴细胞的IL 2表达 ,结合临床患者骨髓移植后aGVHD发生情况 ,与本科室未行G CSF动员的类同病情、年龄及供、受者有可比性 ,且在同一时期内连续进行的 15例骨髓移植病人aGVHD发生情况进行比较。结果表明 ,7例供者经G CSF动员后外周血及骨髓淋巴细胞IL 2表达与未动员前相比明显减少 ,且接受移植的患者未发生Ⅱ度以上aGVHD ,与既往连续进行移植未行G CSF动员的 15例比较 ,aGVHD有降低趋势。上述结果提示 ,经G CSF动员后 ,供者表达IL 2的淋巴细胞明显减少 ,可能与异基因骨髓移植后患者aGVHD发生减低有关。 In this study, to investigate the effect on expression of IL 2 in lymphocytes from bone marrow and peripheral blood of normal donors after they were mobilized by G CSF in allo BMT, 7 normal donors′ bone marrow and peripheral blood were harvested before and after G CSF administration. The separated lymphocytes were measured by FCM after they were stained intracellularly by anti IL 2, and their expression of IL 2 were compared. The degree of aGVHD in patients after bone marrow transplantation was evaluated clinically, and it was compared with the status of aGVHD of 15 patients whose donors didn′t receive G CSF administration in our department, and 2 groups of patients are comparable in age, types of diseases and status of donors. The results showed that the expression of IL 2 in lymphocytes in 7 G CSF mobilized donors decreased significantly after G CSF administration and more severe aGVHD than grade Ⅱ didn′t develop in these recipient patients, and comparing with 15 patients received the bone marrow from donors who didn′t receive G CSF, the incidence of aGVHD decreased. It is suggested that the expression of IL 2 in lymphocytes was influenced by donors′ G CSF administration, and it is likely that thereby reduces the incidence of aGVHD in patients after BMT.
出处 《中国实验血液学杂志》 CAS CSCD 2002年第2期138-141,共4页 Journal of Experimental Hematology
  • 相关文献

参考文献14

  • 1Pan L, Delmonte J, Jalonen CK, et al. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lympho-cytes toward type-2 cytokine production and reduces severity of ex-perimental graft-versus-host disease. Blood, 1995; 86: 4422 - 4429
  • 2Przepioka D, Weisdorf D, Martin P, et al. Consensus conference on acute GVHD grading. BMT, 1995; 15:825 - 828
  • 3Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol, 1989; 7:145 - 173
  • 4Romagnani S. The Th1/Th2 paradigm. Immunol Today, 1997;18:263 - 266
  • 5Piecinni MP, Giudizi MG, Biagiotti R, et al. Progesterone favors the development of human T helper cells producing Th2-type cyto-kines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol, 1995; 155:128 - 133
  • 6Zeng D, Dejbakhsh Jones S, Strober S. Granulocyte colony-stimu-lating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplant-ation. Blood, 1997; 90:453- 463
  • 7Fowler DH, Kurasawa K, Smith R, et al. Donor CD4- enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood, 1994; 84:3540- 3549
  • 8Krenger W, Snyder KM, Byon JC, et al. Polarized type 2 alloreac-tive CD4 + and CD8 + donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol, 1995; 155:585- 593
  • 9Korbling M, Huh YO, Durett A, et al. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primi-tive hematopoietic progenitor cells (CD34+ Thy-1 dim) and lym-phoid subsets, and possible predictors of engraftment and graft-ver-sus-host disease. Blood, 1995; 86:2842 - 2848
  • 10Fowler DH, Kurasawa K, Husebekk A, et al. Cells of Th2 cyto-kine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment. J Immunol, 1994; 152:1004-1013

同被引文献15

  • 1Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med, 1985; 313:765 - 771
  • 2Anasetti C, Amos D, Beatty PG, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med, 1989; 320:197 - 204
  • 3Henslee-Downey PJ, Abhyankar SH, Parrish RS, et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood, 1997; 89:3864-3872
  • 4Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med, 1998; 339:1186- 1193
  • 5Lamb LS Jr, Gee AP, Parrish RS, et al. Acute rejection of marrow grafts in patients transplanted from a partially mismatched related donor: clinical and immunologic characteristic. Bone Marrow. Transplant, 1996; 17:1021 - 1027
  • 6Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant, 1995;15: 825 - 828
  • 7Lamb LS Jr, Gee AP, Henslee-Downey PJ, et al. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors. Bone Marrow Transplant, 1998; 21:461 -471
  • 8Pan L, Delmonte J Jr, Jalonen CK, et al. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood, 1995; 86: 4422 -4429
  • 9Reddy V, Hill GR, Pan L, et al. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. Transplantation, 2000; 69: 691 - 693
  • 10Ji SQ, Chen HR, Xun CQ, et al. The effect of G-CSF stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation. Clin Transplant,2001; 15:317 - 323

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部